Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis

(2016) Paul Welsh et al.   ATHEROSCLEROSIS

Insulin Resistance is Associated with Increased Concentrations of NT-proBNP in Rheumatoid Arthritis: IL-6 as a Potential Mediator

(2014) William S. Bradham et al.   INFLAMMATION

Tocilizumab Treatment Increases Left Ventricular Ejection Fraction and Decreases Left Ventricular Mass Index in Patients with Rheumatoid Arthritis without Cardiac Symptoms: Assessed Using 3.0 Tesla Cardiac Magnetic Resonance Imaging

(2014) H. Kobayashi et al.   JOURNAL OF RHEUMATOLOGY

Prognosis of Individuals With Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA)

(2012) Joseph Yeboah et al.   CIRCULATION

Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases

(2012) Ľubomír Tomáš et al.   CLINICAL RHEUMATOLOGY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide

(2012) P. J. KOTYLA et al.   JOURNAL OF RHEUMATOLOGY

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

(2012)   LANCET

Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study

(2012) Jon T Giles et al.   ARTHRITIS RESEARCH & THERAPY

Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease

(2011) Cynthia S. Crowson et al.   ARTHRITIS CARE & RESEARCH

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis

(2010) A. T. Yan et al.   EUROPEAN HEART JOURNAL

Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

(2010) Giselle C. Meléndez et al.   HYPERTENSION

Tumour necrosis factor   blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

(2009) M. J. L. Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders

(2009) Wilfried Dinh et al.   Cardiovascular Diabetology

Biomarkers of inflammation in heart failure

(2009) Biykem Bozkurt et al.   HEART FAILURE REVIEWS

Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β

(2009) Rudolf Jarai et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

(2008) N Nishimoto et al.   ANNALS OF THE RHEUMATIC DISEASES

Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis

(2008) Joseph Solus et al.   ARTHRITIS AND RHEUMATISM